1st International Congress of
Gynecological Oncology

VIRTUAL CONGRESS

9 -11 July 2020,
Bucharest, Romania

Scientific program

Thursday, July 9th, 2020

Official opening of the event

09:40-10:15

His Excellency Emil Hurezeanu - Ambassador of Romania in Germany
Prof. Dr. H. Kroemer - Charité Chief Executive Officer
Prof. Dr. V. Jinga - Rector of the “Carol Davila” University of Medicine Bucharest; Romania.
Conf. univ. Dr. Diana Păun - Consilier Prezidential, Departamentul Sanatate Publica, Administratia Prezidentiala
Prof. Dr. EI Braicu, Prof. Dr. Gh Peltecu, Prof. Dr. J. Sehouli

Breast cancer
Chairs: M. Untch, D. Median

10:15-10:30
Hereditary breast and ovarian cancer.
F. Nedelea
10:30-10:45
New insights into surgical treatment of breast cancer.
Al Blidaru
10:45-11:00
Treatment landscape of advanced hormone positive breast cancer patients.
M. Untch
11:00-11:15
Targeted therapies and new insight in the therapy of HER2-positive breast cancer patients.
M. Dediu
11:15-11:30
Discussion
11:30-11:45
Break
Visit our Industry Virtual Hall
11:45:12:00
Role of neoadjuvant treatment triple negative breast cancer.
N. Gales
12:00-12:15
Roche Symposium
Treatment options for triple negative metastatic breast cancer
M. Untch
12:15-12:30
PARPinhibition in breast cancer patients.
D. Median
12:30-12:45
Treatment of bone metastatic disease.
G. Kacso
12:45-13:00
Breast cancer and pregnancy
AM Panaitescu
13:00-13:15
Discussion
13:15-14:00
Break
Visit our Industry Virtual Hall

Cervical cancer
Chairs: P. Wimberger, Gh. Peltecu

14:00-14:15
Pfizer Symposium
From clinical trial to clinical practice: Optimizing outcomes in a new age of BC therapy
D. Median
14:15-14:30
Cervical cancer screening landscape in 2020.
M. Gultekin
14:30-14:45
From angiogenesis blockade to checkpoint inhibition in cervical cancer.
D. Lorusso
14:45-15:00
Role of minimal invasive surgery in cervical cancer.
P. Wimberger
15:00-15:15
Role of sentinel lymphadenectomy in Endometrial Cancer
O. Dorigo
15:15-15:30
Discussion
15:30-15:45
Break
Visit our Industry Virtual Hall

Immune therapies in gynecological oncology
Chairs: L. Kandalaft, O. Dorigo

15:45-16:00
Immunology and role of tumor microenvironment in gynecological cancers
O. Dorigo
16:00-16:15
Principles of cellular and immunotherapies in gynecologic oncology.
L. Kandalaft
16:15-16:30
Immune checkpoint blockade in gynecological cancers
D. Stanculeanu
16:30-16:45
Diagnosis and management of immunotherapy toxicities.
EI Braicu
16:45-17:00
Discussion

Friday, July 10th, 2020

A pathway to personalised care in ovarian cancer
Session held with suport of Astra Zeneca (08:45 - 09:30)

08:45-09:00
Prevalence of BRCA mutations and correlations with clinical characteristics in patients with ovarian cancer in Romania (PREDICT)
D. Stanculeanu
09:00-09:30
Rationale for using Parp inhibitors in ovarian cancer patients and Long term follow up results in patients treated with olaparib.
J. Ledermann
09:30-09:45
Discussion

Ovarian Cancer
Chairs: EI Braicu, J. Sehouli

09:45-10:00
Role of Lymph Node dissection in primary ovarian cancer.
C. Fotopoulou
10:00-10:15
Role of surgery in relapsed ovarian cancer.
J. Sehouli
10:15-10:30
PARP inhibition - when is the right time?
J. Ledermann
10:30-10:45
Mechanism of resistance to PARP inhibitors?
C. Gourley
10:45-10:55
Discussion
10:55-11:05
Break
Visit our Industry Virtual Hall
11:05-11:20
Antiangiogenesis – how do we select the timepoint, schedule and population?
S. Pignata
11:20-11:35
Cancer Sociology: Coordinated reprogramming of the tumor and its microenvironment for therapeutic benefit.
H. Gabra
11:35-11:50
Discussion
11:50-12:45
Break
Visit our Industry Virtual Hall

Endometrial and rare cancers
Chairs: H. Gabra, D. Stanculeanu

12:45-13:00
Molecular subtypes of endometrial cancer and their application in clinical decisions.
A. Mustea
13:00-13:15
Current and future directions in endometrial cancer treatment.
M. Mirza
13:15-13:40
Personalized medicine for gynecologic cancers and breast cancer – are we there yet?
EI Braicu; G. Iancu
13:40-13:55
Germ cell tumors of the ovary: diagnosis, prevalence and treatment landscape.
Gh. Peltecu
13:55-14:00
Break
Visit our Industry Virtual Hall
14:00-14:15
Trophoblastic disease: treatment strategies.
M. Seckl
14:15-14:30
Landscape of sarcoma treatment in 2020.
R. Chekerov

Award for best three posters and closing remarks
Chairs: EI Braicu, Gh Peltecu

Saturday, July 11th, 2020
Program Patients Advocacy Day

08:30-08:35
Welcome
Gh Peltecu, EI Braicu
08:35-08:50
Welcome
European and local fight agains Gynecological Cancer, ESGO_ENGAGE and HomeCareAssociation
I. Toth and S. Ene

Scientific session with international experts. Part I
Chairs: EI Braicu, J. Sehouli

08:50-09:00
Risk of hereditary ovarian and breast cancer. Genetic counselling.
EI Braicu
09:00-09:10
Bad cop, good cop in nutrition.
A. Rotmann
09:10-09:20
Role of surgery in ovarian cancer.
C. Fotopoulou
09:20-09:30
Relapsed Ovarian Cancer 2020
J. Sehouli
09:30-09:50
Discussion
09:50-10:00
Break
Visit our Industry Virtual Hall

Scientific session with international experts. Part II
Chairs: Gh. Peltecu, O. Trifanescu

10:00-10:10
What should we know about PARP inhibitors?
M. Untch
10:10-10:25
Roche Symposium
Antiangiogenesis – is this working?
C. Nitipir
10:25-10:40
Immune therapies – miracle or reality?
L. Kandalaft
10:40-10:50
How can art help me?
A. Pirmorady
10:50-11:00
Challenges in cervical cancer treatment
O. Trifanescu
11:00-11:20
Discussion

11:20-11:30
Farewell
EI Braicu, Gh. Peltecu